Literature DB >> 2137460

Affinity chromatographic isolation of the melanoma adhesion receptor for the IIICS region of fibronectin and its identification as the integrin alpha 4 beta 1.

A P Mould1, L A Wheldon, A Komoriya, E A Wayner, K M Yamada, M J Humphries.   

Abstract

Eukaryotic cells adhere to at least two different regions of the fibronectin molecule: a central domain present in all fibronectin isoforms, and the type III connecting segment domain (IIICS), the expression of which is controlled by complex alternative splicing of precursor mRNA. Using affinity chromatography on a matrix containing a synthetic peptide ligand (CS1) representing the strongest active site within the IIICS, we have isolated the human melanoma cell receptor recognizing this region of fibronectin. The receptor is a complex of two polypeptides with subunit molecular masses of 145 and 125 kDa. This heterodimeric structure resembles that of receptors for other extracellular matrix proteins. Immunological analysis with specific antibodies identified these polypeptides as the integrin subunits alpha 4 and beta 1. In addition, antifunctional monoclonal antibodies directed against either alpha 4 or beta 1, but not against other integrin subunits, were potent inhibitors of CS1-mediated melanoma cell spreading. Furthermore, when the function of the central cell-binding domain was blocked, anti-alpha 4 and anti-beta 1 antibodies abolished spreading of A375-M cells on fibronectin, indicating that alpha 4 beta 1 is an authentic fibronectin receptor. Taken together, these results identify the human fibronectin IIICS receptor as the integrin heterodimer alpha 4 beta 1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2137460

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Tissue engineering in the vascular graft.

Authors:  S P Massia; J A Hubbell
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Multiple loop structures critical for ligand binding of the integrin alpha4 subunit in the upper face of the beta-propeller mode 1.

Authors:  A Irie; T Kamata; Y Takada
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Alternative splicing of endothelial cell fibronectin mRNA in the IIICS region. Functional significance.

Authors:  O Kocher; S P Kennedy; J A Madri
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

4.  Distinct mechanism of human neuroblastoma cell adhesion to fibronectin.

Authors:  T Yoshihara; S Ikushima; Y Shimizu; N Esumi; S Todo; M J Humphries; S Imashuku
Journal:  Clin Exp Metastasis       Date:  1991 Jul-Aug       Impact factor: 5.150

5.  A novel region of the alpha4 integrin subunit with a modulatory role in VLA-4-mediated cell adhesion to fibronectin.

Authors:  M Muñoz; J Serrador; M Nieto; A Luque; F Sánchez-Madrid; J Teixidó
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

Review 6.  Integrins.

Authors:  E Ruoslahti
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

7.  A role for decorin in controlling proliferation, adhesion, and migration of murine embryonic fibroblasts.

Authors:  Z Ferdous; S B Peterson; H Tseng; D K Anderson; R V Iozzo; K J Grande-Allen
Journal:  J Biomed Mater Res A       Date:  2010-05       Impact factor: 4.396

8.  Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein.

Authors:  J L Guan; J E Trevithick; R O Hynes
Journal:  Cell Regul       Date:  1991-11

9.  Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.

Authors:  A J Coito; L F Brown; J H Peters; J W Kupiec-Weglinski; L van de Water
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 10.  Cartilage destruction by matrix degradation products.

Authors:  Tadashi Yasuda
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.